cetrorelix Injectable Solution

Brand(s): Cetrotide
Category(s): prescription
SPL Type(s): Human Prescription
Master SPL: Emd Serono, Inc. (2014-05-09)
Oldest Current Product: 2000-08-11
License(s): NDA

RxNORM: INJECTABLE SOLUTION\CETRORELIX
FDAOB: INJECTION\INJECTION\CETRORELIX\rdfq

product(s) by strength(s)

cetrorelix 0.25 mg/ml injectable solution

original product(s)(s)

#	id	brand	category	labeler	first marketed	active ingredient(s)	dose form	application	spl
1	440871225	Cetrotide	NDA	Emd Serono, Inc.	2000-08-11	CETRORELIX ACETATE	KIT	NDA021197	aca7768e-28a7-4027-b1d8-e66247665f79

application(s)

#	id	title	applicant	approved	patent	approved drug
1	NDA021197	CETROTIDE	EMD SERONO INC	2000-08-11	p6319192, PREVENTION OF PREMATURE LH SURGES IN WOMEN UNDERGOING CONTROLLED OVARIAN STIMULATION	NDA021197_001, NDA021197_002

application drug(s)

#	id	category/deprecated	ingredient strength(s)	dose form	rld	approved	application
1	NDA021197_001	RX	CETRORELIX (EQ 0.25MG BASE/ML)	INJECTION	True	2000-08-11	CETROTIDE
2	NDA021197_002	discontinued	CETRORELIX (EQ 3MG BASE/ML)	INJECTION	False	2000-08-11	CETROTIDE

patent(s)

#	id	expiration date	application(s)
1	p6319192 (view patent)	2019-04-23	NDA021197

spl(s)

#	id	title	category	type	labeler	last update	version	product(s)
1	aca7768e-28a7-4027-b1d8-e66247665f79 (view SPL)	Cetrotide 0.25 mg (cetrorelix acetate for injection)	prescription	Human Prescription	Emd Serono, Inc.	2014-05-09	6	440871225

Data from: FDAOB, FDAPB, LOINC, MTHSPL, NDFRT, NCIT, RxNORM, UNII